Reduced risk of human lung cancer by selective cyclooxygenase 2 (COX-2) blockade: results of a case control study - Wikidata - awgldk - TriplyDB

Reduced risk of human lung cancer by selective cyclooxygenase 2 (COX-2) blockade: results of a case control study

Reduced risk of human lung cancer by selective cyclooxygenase 2 (COX-2) blockade: results of a case control study

http://www.wikidata.org/entity/Q28217572

about

Use of acetaminophen in relation to the occurrence of cancer: a review of epidemiologic studies Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward Modeling of non-steroidal anti-inflammatory drug effect within signaling pathways and miRNA-regulation pathways Cyclooxygenase-2 and the inflammogenesis of breast cancer.Phase II, randomized, placebo-controlled trial of neoadjuvant celecoxib in men with clinically localized prostate cancer: evaluation of drug-specific biomarkers.The Role of Non-Steroidal Anti-Inflammatory Drugs in the Chemoprevention of Breast Cancer.The influence of Cox-2 and bioactive lipids on hematological cancers.Characterization of scavengers of gamma-ketoaldehydes that do not inhibit prostaglandin biosynthesis.Does administration of non-steroidal anti-inflammatory drug determine morphological changes in adrenal cortex: ultrastructural studies Platelets and cancer: a casual or causal relationship: revisited.Clinical use and pharmacological properties of selective COX-2 inhibitors.Exposure to cyclooxygenase-2 inhibitors and risk of cancer: nested case-control studies Aspirin use and lung cancer risk: a possible relationship? Evidence from an updated meta-analysis.Pharmacological Modulation of Lung Carcinogenesis in Smokers: Preclinical and Clinical Evidence.Candidate cancer-targeting agents identified by expression-profiling arrays.COX-2 Promotes Migration and Invasion by the Side Population of Cancer Stem Cell-Like Hepatocellular Carcinoma Cells Regular adult aspirin use decreases the risk of non-small cell lung cancer among women.Combination regimen with statins and NSAIDs: a promising strategy for cancer chemoprevention.Targeting cyclooxygenase-2 in hematological malignancies: rationale and promise Aspirin-induced Bcl-2 translocation and its phosphorylation in the nucleus trigger apoptosis in breast cancer cells Cyclooxygenase inhibitors: scope of their use and development in cancer chemotherapy.Reduction in cancer risk by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors.Levuglandin forms adducts with histone h4 in a cyclooxygenase-2-dependent manner, altering its interaction with DNA.FAT1 acts as an upstream regulator of oncogenic and inflammatory pathways, via PDCD4, in glioma cells.The aryl hydrocarbon receptor attenuates tobacco smoke-induced cyclooxygenase-2 and prostaglandin production in lung fibroblasts through regulation of the NF-kappaB family member RelB.Wogonin, a bioactive flavonoid in herbal tea, inhibits inflammatory cyclooxygenase-2 gene expression in human lung epithelial cancer cells.Beclin 1 acetylation impairs the anticancer effect of aspirin in colorectal cancer cells.Concentration-dependent differing actions of the nonsteroidal anti-inflammatory drug, celecoxib, in distearoyl phosphatidylcholine multilamellar vesicles.Organ specificity of beta-carotene induced lung gene-expression changes in Bcmo1-/- mice.Structural Probing, Screening and Structure-Based Drug Repositioning Insights into the Identification of Potential Cox-2 Inhibitors from Selective Coxibs.Cyclooxygenase 2: protein-protein interactions and posttranslational modifications.Monoglyceride lipase gene knockout in mice leads to increased incidence of lung adenocarcinoma.Downregulation of NF-κB and PCNA in the regulatory pathways of apoptosis by cyclooxygenase-2 inhibitors in experimental lung cancer.Effects of aspirin on proliferation, invasion and apoptosis of Hep-2 cells via the PTEN/AKT/NF-κB/survivin signaling pathway.Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies.Modulation of genomic and epigenetic end-points by celecoxib

P2860

Q28075857-071436D8-76C6-4BE1-9C1C-0211D7CE0BE4 Q28274081-A5239E81-BB51-425B-9173-E518CC9E9DAF Q28535339-B94B6A98-54DB-4CD7-8C86-0F989ED92E9B Q30367680-58E75ACE-7A46-4A5E-BBDE-DB755D029B5D Q33561179-83DF0259-6A3E-4307-86B4-0D6C8B9F35BE Q33664316-9E8098C7-EDAF-4BC5-8578-CE056C70C805 Q33688673-1C0D81BC-45AA-44CE-A3CC-0ECA0DA0FE13 Q33701495-EA40A37A-2E36-41B7-8641-1B5A9FFE35BB Q34161193-D75A3D0A-E014-4B3C-B5F4-EDEE27817780 Q34294719-DAFDA050-DBDA-43BD-8306-078A3132ECFA Q34713083-58BCE600-CB8A-4D42-9FE8-2CC6330CF5F0 Q35212665-8FA980D7-9647-4DEB-AEA2-6F36BE878431 Q35306580-42EB8BC9-8471-4E50-9566-F4D2C1D929A6 Q36505700-3B075CED-6515-49DF-831C-18BDC3F72D56 Q36802115-606932C3-597F-4D68-BF64-E797E81E3B09 Q37026129-7F651901-C272-4750-86CA-E742F1B14E79 Q37165596-F2202F64-3D74-41F9-9039-49E2EB460F98 Q37189495-6498EED0-01FA-4831-A7D1-DC2CD3D46FD8 Q37239890-4E314D71-6AEE-48EE-AA84-A04AF7E61824 Q37258255-7E2DB9F3-70E2-4FB8-A395-9D0573D01D5E Q37646513-8B3EA748-CDBD-47CD-B14D-8BFA4219583E Q38836067-9EFF9FC8-9D4B-4566-9142-7A72CB37017E Q39044729-96D6FB24-75E3-4330-A90D-7629D3DF88FA Q39276818-81B964A7-BF7C-4BF8-B285-79F65CEA358F Q39951464-2A5B35C7-B90E-497E-A428-207F4952DFCF Q39979721-2A57D4C3-4D63-480B-96B1-91C0FA75DF0D Q42709414-ED3FB811-92EA-45C9-9E1F-6677F1A10871 Q43256754-B08F5CF5-C013-40D3-96A5-4FD14054EECA Q46454893-0FA6632F-D744-4AB9-A6D6-628C69E6E76E Q47298451-55BE1F97-733E-4FCC-90E2-C966038B9A96 Q47758719-E102EFE2-3805-40A7-B6D9-127456447A72 Q49952999-DEC9506B-DBFD-41DF-B5E0-8848D302BAD0 Q53268368-CA561CA5-D8FA-4F16-877B-B493F876F849 Q54978007-FCADB35B-4F04-4493-8705-42554A4C89CD Q55312563-E6F040A8-095F-4731-AE1F-64ADB69FCDD7 Q58739896-8E8D6CFC-8421-40A5-BF67-D33CDB44E181

P2860

Reduced risk of human lung cancer by selective cyclooxygenase 2 (COX-2) blockade: results of a case control study

http://www.wikidata.org/entity/Q28217572

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Reduced risk of human lung can ...... esults of a case control study

@ast

Reduced risk of human lung can ...... esults of a case control study

@en

Reduced risk of human lung can ...... esults of a case control study

@nl

type

label

Reduced risk of human lung can ...... esults of a case control study

@ast

Reduced risk of human lung can ...... esults of a case control study

@en

Reduced risk of human lung can ...... esults of a case control study

@nl

prefLabel

Reduced risk of human lung can ...... esults of a case control study

@ast

Reduced risk of human lung can ...... esults of a case control study

@en

Reduced risk of human lung can ...... esults of a case control study

@nl

P1433

Q28217572-79E24DD5-7E87-4A9F-BFD9-DCFEE2AF9C22

P1476

Q28217572-E0F3A831-4DA4-444F-A5AB-0039AE7F42C6

P2093

Q28217572-03E37A47-C9D8-4ADC-9FFA-B8DAE5F5A2C5

Q28217572-5F59F61A-9C8C-42A2-86D6-566C12B6A5B0

Q28217572-FF8AA955-ECB9-49EC-A13F-4808C11F6A2F

P2860

Q28217572-043440C7-A76E-4752-9F24-CB677B2520CC

Q28217572-06CAD56D-6B46-4FFF-946F-FE03CD1BA907

Q28217572-075C633E-AD06-4588-9B4E-F8B8CE646B3B

Q28217572-1240F059-8071-4396-ABE0-916903D6DCBE

Q28217572-128B6055-CFFA-47CB-A4E4-714BC8F67FE7

Q28217572-1E02E641-1429-48CE-BF7B-5F4410612155

Q28217572-284B9ABB-8809-4D57-B046-F8090D691821

Q28217572-29E29D91-8602-4396-9B52-10B6A7913990

Q28217572-39050443-B2D7-464C-9C1B-2288B3F85350

Q28217572-3D0A2CD5-D6C8-465C-B82E-0564A8DAED7A

P304

Q28217572-2D44383C-30EE-4E63-A444-F1648A663509

P31

Q28217572-D6528532-5255-469E-BD37-2B595900D080

P3181

Q28217572-A6961FEC-1FB5-419B-AE3C-7C0828C34458

P356

Q28217572-7FDAC380-5217-48FC-ABF7-825F84AED2F7

P407

Q28217572-CCC6258B-4BD9-4564-ADEF-A1EA21366E7F

P433

Q28217572-81FE0098-CF68-4ECD-B185-52B6369EFF93

P478

Q28217572-233BA69F-2542-4CFC-9972-38F715ED31EB

P577

Q28217572-EE9D1110-2ABC-4D3F-85E2-644EDE29C451

P698

Q28217572-E3FCE2A3-9ABF-40FF-AAFE-E71BFD9E55F8

P932

Q28217572-CF19B678-12C3-403E-977D-9C3BA9B09834

P3181

P356

P1433

International Journal of Biological Sciences

P1476

Reduced risk of human lung can ...... esults of a case control study

@en

P2093

Galal A Alshafie

http://www.w3.org/2001/XMLSchema#string

Joanne Beebe-Donk

http://www.w3.org/2001/XMLSchema#string

Randall E Harris

http://www.w3.org/2001/XMLSchema#string

P2860

Human cyclooxygenase-2 cDNA

Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase

Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis

Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

Co-expression of beta-adrenergic receptors and cyclooxygenase-2 in pulmonary adenocarcinoma

Comparison of thromboembolic events in patients treated with celecoxib, a cyclooxygenase-2 specific inhibitor, versus ibuprofen or diclofenac

Chemoprevention of lung cancer by non-steroidal anti-inflammatory drugs among cigarette smokers

Risk of lung carcinoma among users of nonsteroidal antiinflammatory drugs

Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction

P304

328-34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2601813

http://www.w3.org/2001/XMLSchema#string

P356

10.7150/IJBS.3.328

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2007-06-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17589567

http://www.w3.org/2001/XMLSchema#string

P932

1893117

http://www.w3.org/2001/XMLSchema#string